Your own financials reveal the strategic decisions hiding in plain sight. The market's lens reveals what your board doesn't yet know it's being judged on. Copeland brings both into the same room — and tells you what to do about it.
The most consequential strategic decisions are made without a complete picture. Copeland provides the two lenses every board needs but rarely has simultaneously.
We take your numbers — revenue, invested capital, operating profit, tax — and calculate what your business is actually generating in Economic Profit, by division, against its true cost of capital. Most management teams know which divisions are profitable. Very few know which divisions are creating shareholder value. These are not the same question.
Every stock price embeds an expectation — a specific implied growth rate, a specific assumption about future ROIC. Using Expectations Investing frameworks, Copeland reverse-engineers that assumption and sets it against your actual strategic plan. The gap between what the market expects and what your strategy delivers is where valuation risk lives.
The board that knows its own Economic Profit by division — not just its consolidated P&L — makes fundamentally different capital allocation decisions. Copeland surfaces what those numbers are actually saying about strategy before the next board meeting.
View M&A Pricing →When an activist appears on the register, when a competitor makes a move, the C-suite that can answer with mathematical precision wins the conversation. Copeland anchors every strategic argument in the company's own financial reality.
View Consulting Pricing →The difference between a good acquisition and a value-destroying one is not the price — it is whether the board understood the target's Economic Profit trajectory before they signed. Copeland applies the inside-out lens to any target.
View PE Pricing →The board that sees both lenses — what their own financials are saying and what the market is silently concluding — makes fundamentally different governance decisions. Copeland gives you both before the next board meeting.
Start Free Trial →Most boards receive financial reporting. Very few receive financial insight. The gap between the two is where strategy goes wrong.
The P&L shows revenue and profit. It does not show whether the capital deployed to generate that profit is earning above its cost. A division can be profitable and still be destroying shareholder value — if ROIC sits below WACC.
Copeland's inside-out lens: your own financials, decomposed to reveal where Economic Profit is positive, negative, and why.
Every stock price contains an implied growth assumption. Most boards do not know what theirs is. When strategy is built without knowing what the market already expects, capital gets allocated to meet a growth target the market never required.
Copeland's outside-in lens: the market's price-implied expectations, reverse-engineered and set against your strategic plan.
The integration of the inside-out and outside-in view produces a strategic answer: a clear, mathematically grounded picture of where value creation is possible, where it is not, and what the board needs to decide.
Copeland's strategic output: not a valuation. A decision. Anchored in your business. Stress-tested against the market.
The macroeconomic baseline and the company's current position within its industry sector.
The mathematically identified Value Leak — margin compression, ballooning Invested Capital, or a negative ROIC–WACC spread.
What operational levers must management pull immediately to stop the value destruction?
The strategic playbook — divestitures, pricing power, CapEx reduction — required to optimise Economic Profit.
"When committed backlog is misclassified as speculative growth, the implied growth rate a board reads from its valuation can overstate what the company must actually do to justify its share price — and strategy and capital follow the wrong signal."
See exactly what your Investment Committee, board, or deal desk would receive. Every teardown uses live regulatory data, institutional-grade ROIC/WACC/NOPLAT decomposition, and a McKinsey SCQA narrative.
Commission a bespoke institutional SVA — your target, your financials, your Investment Committee's questions answered. Delivered in under 48 hours with a fully unlocked Excel model.
Request a Teardown →For boards who need a live feed into the value reality of their business — not just an annual point-in-time snapshot. Four times a year, your board receives both lenses.
Full inside-out teardown on latest annual filings. Economic Profit by segment. ROIC vs. WACC spread. Strategic gap identification.
Updated on interim filings. Peer ROIC benchmark refresh. Capital allocation efficiency review. Early warning on value-destroying trends.
Full expectations recalibration. Gap between market expectation and your strategy — widened or closed? Board-ready strategic implications.
Full-year synthesis. Capital allocation recommendations ranked by value creation potential. Outside-in gap analysis. Board presentation-ready.
Monthly inside-out value refresh showing whether strategic initiatives are converting to measurable value.
Five Copeland Dossiers per month, triggered on demand, delivered in under two hours. A retained analytical partner.
A single, complete institutional SVA on any target — public or private. The full picture in one white-label-ready package.
SVA Master Methodology PDF · Executive Summary on a company of your choosing · Methodology Overview. Requests must originate from a verified enterprise email address.
"The most dangerous strategic decisions are made by boards that know their own business well — but have never been shown what the market is silently concluding about it."
Copeland Research was built on a single conviction: every board making a consequential strategic decision deserves both lenses simultaneously. The Copeland SVA Engine runs live at value.scangeni.us. The methodology honours Tom Copeland, whose foundational work on NOPLAT, ROIC, and Expectations Investing defines our methodological spine.
ScanGeni Ventures · Accenture Strategy (25 yrs) · Metyis. 29 years across strategy, corporate finance, and AI-native product development.
Author — The Krishna Cipher · When Quiet Becomes Home. Scripta Indica imprint.
Open to qualified applications. Senior practitioners — PE principals, CFOs, strategy partners, academics. Applications reviewed quarterly. Apply →
One teardown summary · one new POV preview · one SVA diagnostic that changes how you read a valuation.
Subscribe →